Arrowhead Pharmaceuticals Inc (ARWR) Insider Trading
- $301,336.35
- $153,524,219.18
- April 23, 2026
- Christopher Richard Anzalone
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| April 23, 2026 | Insider | 10,000 | $75.00 | Sell | $750,000.00 | |
| April 22, 2026 | CFO | 13,095 | $71.35 | Sell | $934,328.25 | |
| March 5, 2026 | Insider | 10,000 | $64.19 | Sell | $641,900.00 | |
| Sept. 12, 2025 | Insider | 15,000 | $30.00 | Sell | $450,000.00 | |
| Sept. 2, 2025 | Insider | 15,000 | $25.00 | Sell | $375,000.00 | |
| Aug. 15, 2025 | Insider | 9,389 | $20.00 | Sell | $187,780.00 | |
| Aug. 13, 2025 | Insider | 611 | $20.00 | Sell | $12,220.00 | |
| April 11, 2025 | CEO | 50,800 | $11.49 | Sell | $583,692.00 | |
| April 9, 2025 | CEO | 40,322 | $10.07 | Sell | $406,042.54 | |
| March 13, 2025 | CEO | 51,425 | $15.07 | Sell | $774,974.75 | |
| March 4, 2025 | CEO | 133,333 | $17.02 | Sell | $2,269,327.66 | |
| Jan. 23, 2025 | Director | 959 | $21.00 | Sell | $20,139.00 | |
| Jan. 6, 2025 | COO | 29,184 | $19.82 | Sell | $578,426.88 | |
| Jan. 6, 2025 | CFO | 27,167 | $19.83 | Sell | $538,721.61 | |
| Jan. 6, 2025 | Insider | 32,729 | $19.82 | Sell | $648,688.78 | |
| Jan. 2, 2025 | CEO | 11,520 | $19.05 | Sell | $219,456.00 | |
| Dec. 27, 2024 | Director | 2,850 | $20.00 | Sell | $57,000.00 | |
| Dec. 23, 2024 | CEO | 12,563 | $19.59 | Sell | $246,109.17 | |
| Dec. 18, 2024 | CEO | 26,712 | $21.24 | Sell | $567,362.88 | |
| Dec. 16, 2024 | Director | 3,748 | $21.90 | Sell | $82,081.20 | |
| July 2, 2024 | Insider | 9,394 | $25.28 | Sell | $237,480.32 | |
| May 2, 2024 | Director | 1,799 | $23.31 | Sell | $41,934.69 | |
| March 20, 2024 | Director | 1,000 | $27.50 | Buy | $27,500.00 | |
| March 18, 2024 | Director | 1,000 | $27.49 | Buy | $27,490.00 | |
| March 6, 2024 | CFO | 40,000 | $35.19 | Sell | $1,407,600.00 | |
| Jan. 31, 2024 | CEO | 57,499 | $32.35 | Sell | $1,860,092.65 | |
| Jan. 12, 2024 | Insider | 7,940 | $36.89 | Sell | $292,906.60 | |
| Jan. 11, 2024 | Director | 2,911 | $38.06 | Sell | $110,792.66 | |
| Jan. 5, 2024 | COO | 22,841 | $35.27 | Sell | $805,602.07 | |
| Jan. 5, 2024 | Insider | 32,143 | $35.18 | Sell | $1,130,790.74 | |
| Jan. 5, 2024 | CFO | 16,104 | $35.27 | Sell | $567,988.08 | |
| Jan. 3, 2024 | COO | 8,749 | $32.28 | Sell | $282,417.72 | |
| Jan. 3, 2024 | Insider | 6,300 | $32.19 | Sell | $202,797.00 | |
| Jan. 2, 2024 | CEO | 9,952 | $31.01 | Sell | $308,611.52 | |
| Dec. 20, 2023 | CEO | 12,000 | $28.54 | Sell | $342,480.00 | |
| Nov. 20, 2023 | Insider | 19,700 | $28.80 | Sell | $567,360.00 | |
| Oct. 25, 2023 | CEO | 24,338 | $24.21 | Sell | $589,222.98 | |
| Sept. 28, 2023 | Director | 1,550 | $26.33 | Sell | $40,811.50 | |
| Sept. 18, 2023 | CEO | 57,755 | $28.12 | Sell | $1,624,070.60 | |
| July 3, 2023 | Insider | 8,925 | $35.31 | Sell | $315,141.75 | |
| June 30, 2023 | Insider | 3,000 | $35.53 | Sell | $106,590.00 | |
| June 27, 2023 | CFO | 15,000 | $36.20 | Sell | $543,000.00 | |
| May 5, 2023 | Director | 6,500 | $40.90 | Sell | $265,850.00 | |
| May 3, 2023 | CEO | 54,928 | $39.14 | Sell | $2,149,881.92 | |
| March 3, 2023 | Director | 11,350 | $32.65 | Sell | $370,577.50 | |
| Feb. 27, 2023 | Director | 875 | $32.62 | Sell | $28,542.50 | |
| Jan. 9, 2023 | Director | 3,200 | $30.00 | Sell | $96,000.00 | |
| Jan. 5, 2023 | COO | 15,000 | $37.39 | Sell | $560,850.00 | |
| Jan. 5, 2023 | Insider | 13,803 | $37.40 | Sell | $516,232.20 | |
| Jan. 3, 2023 | COO | 17,500 | $38.33 | Sell | $670,775.00 |
Insiders are both buying and selling Arrowhead Pharmaceuticals Inc stock.
The insider traders at Arrowhead Pharmaceuticals Inc are: Christopher Richard Anzalone, Kenneth Allen Myszkowski, James C Hamilton, Bruce D Given, Patrick O'brien, Douglas B Given, Douglas B. Given, Backer Marianne De, William D Waddill, Adeoye Y Olukotun, Martin Javier San, Mauro Ferrari, Michael S Perry, Victoria Vakiener, Hongbo Lu, Tracie Oliver, Charles Mckenney, David L Lewis, James Hassard, Edward W Frykman, Zhen Li, Daniel Joseph Apel, and Peter Brian Leone
The most active insider trader at Arrowhead Pharmaceuticals Inc is Christopher Richard Anzalone with 35 trades.
Christopher Richard Anzalone has sold the most Arrowhead Pharmaceuticals Inc stock with a total value of $67,519,650.41.
Christopher Richard Anzalone has bought the most Arrowhead Pharmaceuticals Inc stock with a total value of $202,240.00.
The most recent insider trade for Arrowhead Pharmaceuticals Inc was on April 23, 2026.
The single biggest insider buy for Arrowhead Pharmaceuticals Inc was from Christopher Richard Anzalone with a total value of $101,120.00 on Oct. 15, 2014.
The single biggest insider sell for Arrowhead Pharmaceuticals Inc was from Patrick O'brien with a total value of $7,961,400.00 on Feb. 8, 2021.
